Fundamentals

Valuation

Metric	Q3	Q1	Δ in %
EV/EBITDA	-1.87	67.32	68.61
Graham Fair Price	4.49	15.32	14.66
PEG	1272.18	18.50	1.35
Price/Book	8.46	3.51	3.24
Price/Cash Flow	96.24	183.94	93.73
Prices/Earnings	0.05	38.55	38.53
Price/Sales	6.57	13.46	12.63
Price/FCF	96.24	183.94	93.73
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q1	Δ in %
Gross Profit Margin	3.96	0.47	0.45
Operating Margin	-0.38	0.11	0.11
ROA	-15.02	0.01	0.01
ROE	0.02	0.02	8.41
ROIC	0.02	0.01	-23.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q1	Δ in %
Debt QOQ	-0.02	-0.13	83.61
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.22	0.10	-55.88
EPS QOQ	0.29	0.02	-92.71
FCF QOQ	2.60	-0.57	-78.29
Revenue QOQ	-0.02	< 0.005	-95.43
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q3	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	158.08	158.60	0.33
Days Sales Outstanding (DSO)	54.48	53.44	-1.91
Inventory Turnover	0.57	0.57	-0.33
Debt/Capitalization	0.22	0.41	84.30
Quick Ratio	1.33	4.23	217.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q1	Δ in %
Book Value	21.32	21.40	0.36
Cash	1.02	10.06	889.03
Capex	-0.15	-0.22	-45.24
Free Cash Flow	0.74	0.41	-44.53
Revenue	5.46	5.58	2.14
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q1	Δ in %
Current Ratio	3.13	6.03	92.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.76	4.22	-11.38
Naive Interpretation	Member

06 - Financial Health · Bad

Rating